课题基金 / 基金详情

Treatment of virally-induced cancers by RNA Interference.

Treatment of virally-induced cancers by RNA Interference.
通过 RNA 干扰治疗病毒诱发的癌症。
批准号:
nhmrc : 301121
负责人:
A/Pr Nicholas Saunders
金额:
$25.96万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2006-12-31

项目摘要

项目成果

A/Pr Nicholas Saunders的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancers require certain mutations and the over expression of genes to cause disease. Each cancer has a unique set of gene changes thus making it difficult to treat. However, it has become clear that the normal control mechanisms of many cancers are still intact but are repressed by the over expression of these oncogenes (or cancer genes). By turning off these oncogenes we can restore normal control to the cell and the cancer will die normally. We will use a new method of gene targeting called RNA interference to turn off oncogenes. RNA interference involves treatment of cells with a small peice of genetic material that provides the cell with an identity pattern of the gene to be eliminated. The cell takes the pattern and turms off the genes expression. As long as the pattern only turns off the cancer gene all other genes will remain normal. We will test this using cervical cancer as a model as all these cancers are caused by infection with a virus that carries 2 oncogenes. It is these virus oncogenes that cause the cancer and therefore we know the exact target genes that need to be turned off. Most importantly these genes are not present in normal cells making it safe to target them by RNA interference. We have gathered an expert group of investigators with experience in cervical cancer and cancer genetics to address this problem. If successful we will have proven this new technique can work against cervical cancer and this method could then be applied to any cancer. We would then be able to start human trials. Cervical cancer kills over 300 women in Australia each year, is the leading cause of cancer death in Aboriginal women, is 2nd most common cancer of women in the world and is the leading cancer killer worldwide in women under 50.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterisation of two novel markers of osteosarcoma metastasis as potential therapeutic targets
  • 批准号:
    nhmrc : 1049182
  • 项目类别:
    Project Grants
  • 资助金额:
    $41.64万
  • 财政年份:
    2013
  • 负责人:
    A/Pr Nicholas Saunders
  • 依托单位:
A novel tumour suppressor function of E2F7 in squamous cell carcinoma formation
  • 批准号:
    nhmrc : 569689
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $34.95万
  • 财政年份:
    2009
  • 负责人:
    A/Pr Nicholas Saunders
  • 依托单位:
identification of clinically significant subtypes of head and neck cancer cells
  • 批准号:
    nhmrc : 455929
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $31.28万
  • 财政年份:
    2007
  • 负责人:
    A/Pr Nicholas Saunders
  • 依托单位:
Development of a novel therapy for the treatment of epidermal squamous cell carcinoma
  • 批准号:
    nhmrc : 301075
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $28.86万
  • 财政年份:
    2004
  • 负责人:
    A/Pr Nicholas Saunders
  • 依托单位:
海外基金